Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 6,720 | 17,135 | 0 |
| Operating Income | -6,720 | -17,135 | N/A |
| Other Income | -27,984 | -1,832 | 0 |
| Pre-tax Income | -34,704 | -18,967 | 0 |
| Income Tax | 8 | 3 | N/A |
| Net Income Continuous | -34,712 | -18,970 | N/A |
| Net Income | $-34,712 | $-18,970 | $N/A |
| EPS Basic Total Ops | -0.82 | -0.47 | N/A |
| EPS Basic Continuous Ops | -0.82 | -0.47 | N/A |
| EPS Diluted Total Ops | -0.82 | -0.47 | N/A |
| EPS Diluted Continuous Ops | -0.82 | -0.47 | N/A |
| EBITDA(a) | $-6,720 | $-17,135 | $N/A |